Urolon is a bioresorbable urethral implant for the treatment of stress urinary incontinence (SUI) and inherently different from traditional urethral bulking agents due to its unique performance, mode of action and bioresorption profile. It is a minimally invasive treatment using non-permanent materials that is very suitable as a first-choice treatment option before using permanent injectables or surgical interventions. Its unique characteristics and composition provide the dual action of:
1. immediate bulking effect by the gel carrier
2. sustained performance by the polycaprolactone microspheres and related mechanism of action
Urolon can be administered non-surgically using a transurethral approach via cystoscopy. Urolon offers the following performance properties:
- Immediate bulking effect
- Sustained performance
- Lower associated-risks when compared to surgery2
Immediate bulking effect
Most noticeable is the ability of Urolon to restore lost volume around the urethra by providing an immediate bulking effect due to the optimum visco-elastic gel carrier.
A sustained performance is achieved through the unique mode of action of Urolon and its bioresorption profile.